L. Quartuccio, “Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis”, Reumatismo, vol. 61, no. 3, pp. 182–186, Sep. 2009.